BioAtla Inc (BCAB)’s financial ratios: A comprehensive overview

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.95 million shares were traded. BCAB stock price reached its highest trading level at $1.6401 during the session, while it also had its lowest trading level at $1.55.

Ratios:

To gain a deeper understanding of BCAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 3.81. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on September 15, 2022, initiated with a Mkt Outperform rating and assigned the stock a target price of $17.

On May 05, 2022, Credit Suisse Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $35 to $5.

On March 21, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on March 21, 2022, with a $25 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 26 ’23 when MCBRINN SYLVIA bought 4,000 shares for $2.33 per share. The transaction valued at 9,320 led to the insider holds 15,125 shares of the business.

SHORT JAY M PHD bought 50,000 shares of BCAB for $106,910 on Dec 20 ’23. The Chief Executive Officer now owns 1,439,283 shares after completing the transaction at $2.14 per share. On Dec 19 ’23, another insider, STEINMAN LAWRENCE, who serves as the Director of the company, bought 20,000 shares for $2.05 each. As a result, the insider paid 41,048 and bolstered with 38,459 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAB now has a Market Capitalization of 78787192 and an Enterprise Value of 18787252.

Stock Price History:

Over the past 52 weeks, BCAB has reached a high of $4.02, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -4.84%, while the 200-Day Moving Average is calculated to be -25.27%.

Shares Statistics:

It appears that BCAB traded 906.01K shares on average per day over the past three months and 520820 shares per day over the past ten days. A total of 48.08M shares are outstanding, with a floating share count of 39.01M. Insiders hold about 19.30% of the company’s shares, while institutions hold 43.38% stake in the company. Shares short for BCAB as of 1726185600 were 4450925 with a Short Ratio of 4.91, compared to 1723680000 on 4751601. Therefore, it implies a Short% of Shares Outstanding of 4450925 and a Short% of Float of 10.290000000000001.

Most Popular